Cargando…
Barrett’s Epithelium to Esophageal Adenocarcinoma: Is There a “Point of No Return”?
Background: Esophageal adenocarcinoma (EA) arises from Barrett’s epithelium (BE), and chronic gastroesophageal reflux disease is considered the strongest risk factor for disease progression. All BE patients undergo acid suppressive therapy, surveillance, and BE removal by surgery or endoscopic ablat...
Autores principales: | Panda, Anshuman, Shin, Mi ryung, Cheng, Christina, Bajpai, Manisha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485939/ https://www.ncbi.nlm.nih.gov/pubmed/34603373 http://dx.doi.org/10.3389/fgene.2021.706706 |
Ejemplares similares
-
Recurring Translocations in Barrett’s Esophageal Adenocarcinoma
por: Bajpai, Manisha, et al.
Publicado: (2021) -
Gene Expression in Barrett’s Esophagus Cell Lines Resemble Esophageal Squamous Cell Carcinoma Instead of Esophageal Adenocarcinoma
por: Panda, Anshuman, et al.
Publicado: (2021) -
Origin of Barrett’s Epithelium: Esophageal Submucosal Glands
por: Garman, Katherine S.
Publicado: (2017) -
Metallothionein in human oesophagus, Barrett's epithelium and adenocarcinoma
por: Coyle, P, et al.
Publicado: (2002) -
Prolonged exposure to acid and bile induces chromosome abnormalities that precede malignant transformation of benign Barrett’s epithelium
por: Bajpai, Manisha, et al.
Publicado: (2012)